| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 64.6135 | 67 |
| GSM780708 | Untreated after 4 days (C2_1) | 100.993 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.7551 | 59 |
| GSM780719 | Untreated after 4 days (C1_2) | 63.5961 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 108.047 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 57.8895 | 63 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 96.9017 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 87.7061 | 73 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 126.1 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 94.6807 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 90.2885 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 129.41 | 79 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.662 | 40 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 67.9093 | 68 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 62.1281 | 66 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.2009 | 57 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 67.3431 | 68 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 74.8545 | 70 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 221.201 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 234.321 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 147.336 | 80 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 221.161 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 198.995 | 84 |